Physician profile
Larson Langschwager
NPI 1073515128
$527.00
in general payments reported to CMS, 2019-2025
14 companies · $27.94 in 2025
The $27.94 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $16.30 · 2021: $23.02 · 2022: $159 · 2023: $133 · 2024: $35.84 · 2025: $27.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $85.44 | 2023-2024 | Veozah |
| Abbvie INC. | $84.22 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.58 | 2022-2025 | |
| Organon LLC | $63.83 | 2021-2023 | Nexplanon |
| Myovant Sciences INC. | $45.27 | 2022 | |
| Therapeuticsmd, INC. | $42.75 | 2019-2022 | |
| Pfizer INC. | $19.41 | 2022 | |
| Dexcom, INC. | $19.23 | 2024 | Dexcom G6 Transmitter |
| Channel Medsystems, INC. | $17.96 | 2023 | |
| Hologic Sales and Service, LLC | $17.24 | 2019 | |
| Exeltis, USA INC. | $17.03 | 2022 | |
| Minerva Surgical, INC | $16.42 | 2019 | |
| Lupin INC. | $16.30 | 2020 | |
| Biogen, INC. | $14.32 | 2025 | Zurzuvae |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larson Langschwager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.